Growth hormone therapy and quality of life: Possibilities, pitfalls and mechanisms

Journal of Endocrinology

Volumn 179, Issue 3, 2003, Pages 311-333

  Hull, K L ^b   Harvey, S ^a  

^a BISHOP'S UNIVERSITY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; OXANDROLONE; PLACEBO; RECOMBINANT GROWTH HORMONE;

ADULT; ARTHRALGIA; BODY HEIGHT; CARCINOGENESIS; CARDIOVASCULAR FUNCTION; CARPAL TUNNEL SYNDROME; CHILD; DATA ANALYSIS; DRUG COST; EPIPHYSIOLYSIS; FLUID RETENTION; GLUCOSE INTOLERANCE; GROWTH HORMONE DEFICIENCY; GYNECOMASTIA; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; INSULIN RESISTANCE; INTRACRANIAL HYPERTENSION; INTRAUTERINE GROWTH RETARDATION; LEUKEMIA; LUNG FUNCTION; METABOLISM; MORBIDITY; NERVOUS SYSTEM FUNCTION; PANCREATITIS; PERIPHERAL EDEMA; PIGMENTATION; PRIORITY JOURNAL; QUALITY OF LIFE; REPRODUCTION; REVIEW; SHORT STATURE; SIDE EFFECT; SODIUM RETENTION; TURNER SYNDROME; WATER RETENTION;

ADULT; AGED; AGING; CHILD; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; QUALITY OF LIFE; RECOMBINANT PROTEINS; TURNER SYNDROME;

EID: 0346656882     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1790311     Document Type: Review

References (220)

1. Aberg ND, Carlsson B, Rosengren L, Oscarsson J, Isaksson OG, Ronnback L & Eriksson PS 2000 Growth hormone increases connexin-43 expression in the cerebral cortex and hypothalamus. Endocrinology 141 3879-3886.
2. Ahmad AM, Hopkins MT, Thomas J, Ibrahim H, Fraser WD & Vora JP 2001 Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement. Clinical Endocrinology 54 709-717.
3. Al Shoumer KA, Ali K, Anyaoku V, Niththyananthan R & Johnston DG 1996 Overnight metabolic fuel deficiency in patients treated conventionally for hypopituitarism. Clinical Endocrinology 45 171-178.
4. Aleman A, de Vries WR, de Haan EH, Verhaar HJ, Samson MM & Koppeschaar HP 2000 Age-sensitive cognitive function, growth hormone and insulin-like growth factor-I plasma levels in healthy older men. Neuropsychobiology 41 73-78.
5. Allen DB 1999 Issues in the transition from childhood to adult growth hormone therapy. Pediatrics 104 1004-1010.
6. Allen DB, Brook CC, Bridges NA, Hindmarsh PC, Guyda HJ & Frazier D 1994 Therapeutic controversies: growth hormone (GH) treatment of non-GH deficient subjects. Journal of Clinical Endocrinology and Metabolism 79 1239-1248.
7. Almqvist O, Thoren M, Saaf M & Eriksson O 1986 Effects of growth hormone substitution on mental performance in adults with growth hormone deficiency: a pilot study. Psychoneuroendocrinology 11 347-352.
8. Amato G, Carella C, Fazio S, La Montagna G, Cittadini A, Sabatini D, Marciano-Mone C, Sacca L & Bellastella A 1993 Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. Journal of Clinical Endocrinology and Metabolism 77 1671-1676.
9. Anawalt BD & Merriam GK 2001 Neuroendocrine aging in men. Andropause and somatopause. Endocrinology and Metabolism Clinics of North America 30 647-669.
10. Andronikof-Sanglade A, Fjellestad-Paulsen A, Ricard-Malivoir S & Evain-Brion D 1997 Specific abnormalities in a visual motor psychological test in short children with abnormal growth hormone secretion. Acta Paediatrica 86 154-159.
11. Astrom C & Lindholm J 1990 Growth hormone-deficient young adults have decreased deep sleep. Neuroendocrinology 51 82-84.
12. Astrom C, Pedersen SA & Lindholm J 1990 The influence of growth hormone on sleep in adults with growth hormone deficiency. Clinical Endocrinology 33 495-500.
13. Attanasio AF, Lamberts SW, Matranga AM, Birkett MA, Bates PC, Valk NK, Hilsted J, Bengtsson BA & Strasburger CJ 1997 Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group. Journal of Clinical Endocrinology and Metabolism 82 82-88.
14. Badia X, Lucas A, Sanmarti A, Roset M & Ulied A 1998 One-year follow-up of quality of life in adults with untreated growth hormone deficiency. Clinical Endocrinology 49 765-771.
15. Bareille P, Frazer F & Stanhope R 1999 GH replacement in children: what is the optimum dosing schedule? In Growth Hormone Therapy, pp 3-18. Ed JP Monson. London: Blackwell Science.
16. Barkan AL, Clemmons DR, Molitch ME, Stewart PM & Young WF Jr 2000 Growth hormone therapy for hypopituitary adults: time for re-appraisal. Trends in Endocrinology and Metabolism 11 238-245.
17. Baum HB, Katznelson L, Sherman JC, Biller BM, Hayden DL, Schoenfeld DA, Cannistraro KE & Klibanski A 1998 Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency. Journal of Clinical Endocrinology and Metabolism 83 3184-3189.
18. Becker AJ, Uckert S, Stief CG, Truss MC, Machtens S, Scheller F, Knapp WH, Hartmann U & Jonas U 2000 Possible role of human growth hormone in penile erection. Journal of Urology 164 2138-2142.
19. Becker AJ, Uckert S, Stief CG, Scheller F, Knapp WH, Hartmann U, Brabant G & Jonas U 2002 Serum levels of human growth hormone during different penile conditions in the cavernous and systemic blood of healthy men and patients with erectile dysfunction. Urology 59 609-614.
20. Bengtsson BA, Eden S, Lonn L, Kvist H, Stokland A, Lindstedt G, Bosaeus I, Tolli J, Sjostrom L & Isaksson OG 1993 Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. Journal of Clinical Endocrinology and Metabolism 76 309-317.
21. Bengtsson BA, Johannsson G, Shalet SM, Simpson H & Sonken PH 2000 Treatment of growth hormone deficiency in adults. Journal of Clinical Endocrinology and Metabolism 85 933-942.
22. Beshyah SA, Sharp PS, Gelding SV, Halliday D & Johnston DG 1993 Whole-body leucine turnover in adults on conventional treatment for hypopituitarism. Acta Endocrinologica 129 158-164.
23. Beshyah SA, Freemantle C, Shahi M, Anyaoku V, Merson S, Lynch S, Skinner E, Sharp P, Foale R & Johnston DG 1995a Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults. Clinical 42 73-84.
24. Beshyah SA, Shahi M, Foale R & Johnston DG 1995b Cardiovascular effects of prolonged growth hormone replacement in adults. Journal of Internal Medicine 237 35-42.
25. Bjork S, Jonsson B, Westphal O & Levin JE 1989 Quality of life of adults with growth hormone deficiency: a controlled study. Acta Pediatrica Scandinavia Supplement 356 55-59.
26. Blok GJ, de Boer H, Gooren LJ & van der Veen EA 1997 Growth hormone substitution in adult growth hormone-deficient men augments androgen effects on the skin. Clinical Endocrinology 47 29-36.
27. Boersma B, Rikken B & Wit JM 1995 Catch-up growth in early treated patients with growth hormone deficiency. Dutch Growth Hormone Working Group. Archives of Diseases of Childhood 72 427-431.
28. Boger RH, Skamira C, Bode-Boger SM, Brabant G, von Zur MA & Frolich JC 1996 Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study. Journal of Clinical Investigation 98 2706-2713.
29. Bulow B, Hagmar L, Orbaek P, Osterberg K & Erfurth EM 2002 High incidence of mental disorders, reduced mental well-being and cognitive function in hypopituitary women with GH deficiency treated for pituitary disease. Clinical Endocrinology 56 183-193.
30. Burman P, Broman JE, Hetta J, Wiklund I, Erfurth EM, Hagg E & Karlsson FA 1995 Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial. Journal of Clinical Endocrinology and Metabolism 80 3585-3590.
31. Burman P, Hetta J, Wide L, Mansson JE, Ekman R & Karlsson FA 1996 Growth hormone treatment affects brain neurotransmitters and thyroxine [see comment]. Clinical Endocrinology 44 319-324.
32. Busschbach JJ, Rikken B, Grobbee DE, De C & Wit JM 1998 Quality of life in short adults. Hormone Research 49 32-38.
33. Caidahl K, Eden S & Bengtsson BA 1994 Cardiovascular and renal effects of growth hormone. Clinical Endocrinology 40 393-400.
34. Carroll PV, Littlewood R, Weissberger AJ, Bogalho P, McGauley G, Sonksen PH & Russell-Jones DL 1997 The effects of two doses of replacement growth hormone on the biochemical, body composition and psychological profiles of growth hormone-deficient adults. European Journal of Endocrinology 137 146-153.
35. Carroll PV, Christ ER & Sonksen PH 2000 Growth hormone replacement in adults with growth hormone deficiency: assessment of current knowledge. Trends in Endocrinology and Metabolism 11 231-238.
36. Carter CS, Ramsey MM & Sonntag WE 2002 A critical analysis of the role of growth hormone and IGF-I in aging and lifespan. Trends in Genetics 18 295-301.
37. Castro JR, Costoya JA, Gallego R, Prieto A, Arce VM & Senaris R 2000 Expression of growth hormone receptor in the human brain. Neuroscience Letters 281 147-150.
38. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH & Pollak M 1998 Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279 563-566.
39. Chen L, Lund PK, Burgess SB, Rudisch BE & McIlwain DL 1997 Growth hormone, insulin-like growth factor I, and motoneuron size. Journal of Neurobiology 32 202-212.
40. Chrisoulidou A, Kousta E, Beshyah SA, Robinson S & Johnston DG 1998 How much and by what mechanisms, does growth hormone replacement improve the quality of life in GH-deficient adults? Baillieres Clinical Endocrinology and Metabolism 12 261-279.
41. Christ ER, Cummings MH, Westwood NB, Sawyer BM, Pearson TC, Sonksen PH & Russell-Jones DL 1997 The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 82 2985-2990.
42. Christ ER, Chowienczyk PJ, Sonksen PH & Russel-Jones DL 1999a Growth hormone replacement therapy in adults with growth hormone deficiency improves vascular reactivity. Clinical Endocrinology 51 21-25.
43. Christ ER, Cummings MH, Lumb PJ, Crook MA, Sonksen PH & Russell-Jones DL 1999b Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH-deficiency: a double-blind placebo-controlled study. Clinical Endocrinology 51 173-179.
44. Christ ER, Wierzbicki AS, Cummings MH, Umpleby AM & Russell-Jones DL 1999c Dynamics of lipoprotein metabolism in adult growth hormone deficiency. Journal of Endocrinological Investigation 22 16-21.
45. Christ ER, Simpson HL, Breen L, Sonksen PH, Russell-Jones DL & Kohner EM 2003 The effect of growth hormone (GH) replacement therapy in adult patients with type 1 diabetes mellitus and GH deficiency. Clinical Endocrinology 58 309-315.
46. Coculescu M 1999 Blood-brain barrier for human growth hormone and insulin-like growth factor-I. Journal of Pediatric Endocrinology and Metabolism 12 113-124.
47. Cohen P, Clemmons DR & Rosenfeld RG 2000 Does the GH-IGF axis play a role in cancer pathogenesis? Growth Hormone and IGF-I Research 10 297-305.
48. Colao A, Balzano A, Ferone D, Panza N, Grande G, Marzullo P, Bove A, Iodice G, Merola B & Lombardi G, 1997 Increased prevalence of colonic polyps and altered lymphocyte subset pattern in the colonic lamina propria in acromegaly. Clinical Endocrinology 47 23-28.
49. Colao A, Cuocolo A, Di Somma C, Cerbone G, Morte AM, Pivonello R, Nicolai E, Salvatore M & Lombardi G 2000 Does the age of onset of growth hormone deficiency affect cardiac performance? A radionuclide angiography study. Clinical Endocrinology 52 447-455.
50. Colao A, Marzullo P, Di Somma C & Lombardi G 2001 Growth hormone and the heart. Clinical Endocrinology 54 137-154.
51. Corbacho AM, Martinez, De La Escalera & Clapp C 2002 Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis. Journal of Endocrinology 173 219-238.
52. Crock PA, McKenzie JD, Nicoll AM, Howard NJ, Cutfield W, Shield LK & Byrne G, 1998 Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand. Acta Paediatrica 87 381-386.
53. Cummings DE & Merriam GR 1999 Age-related changes in growth hormone secretion: should the somatopause be treated? Seminars in Reproductive Endocrinology 17 311-325.
54. Cuneo RC, Salomon F, Wiles CM, Hesp R & Sonksen PH 1991a Growth hormone treatment in growth hormorne-deficient adults. I. Effects on muscle mass and strength. Journal of Applied Physiology 70 688-694.
55. Cuneo RC, Salomon F, Wiles CM, Hesp R & Sonksen PH 1991b Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance. Journal of Applied Physiology 70 695-700.
56. Cuneo RC, Salomon F, McGauley GA & Sonksen PH 1992 The growth hormone deficiency syndrome in adults. Clinical Endocrinology 37 387-397.
57. Cuneo RC, Judd S, Wallace JD, Perry-Keene D, Burger H, Lim-Tio S, Strauss B, Stockigt J, Topliss D, Alford F et al. 1998 The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults. Journal of Clinical Endocrinology and Metabolism 83 107-116.
58. Cuttler L, Silvers JB, Singh J, Marrero U, Finkelstein B, Tannin G, & Neuhauser D 1996 Short stature and growth hormone therapy. A national study of physician recommendation patterns. Journal of the American Medical Association 276 531-537.
59. Degerblad M, Almkvist O, Grunditz R, Hall K, Kaijser L, Knutsson E, Ringertz H & Thoren M 1990 Physical and psychological capabilities during substitution therapy with recombinant growth hormone in adults with growth hormone deficiency. Acta Endocrinologica 123 185-193.
60. Deijen JB & van der Veen EA 1999 The influence of growth hormone (GH) deficiency and GH replacement on quality of life in GH-deficient patients. Journal of Endocrinological Investigation 22 127-136.
61. Deijen JB, de Boer H, Blok GJ & van der Veen EA 1996 Cognitive impairments and mood disturbances in growth hormone deficient men. Psychoneuroendocrinology 21 313-322.
62. Deijen JB, de Boer H & van der Veen EA 1998 Cognitive changes during growth hormone replacement in adult men. Psychoneuroendocrinology 23 45-55.
63. Delooz J, van den Berghe H, Swillen A, Kleczkowska A & Fryns JP 1993 Turner syndrome patients as adults: a study of their cognitive profile, psychosocial functioning and psychopathological findings. Genetic Counselling 4 169-179.
64. Donaldson MD 1997 Growth hormone therapy in Turner syndrome - current uncertainties and future strategies. Hormone Research 48 (Suppl 5) 35-44.
65. Dorshkind K & Horseman ND 2000 The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency. Endocrine Reviews 21 292-312.
66. Downie AB, Mulligan J, McCaughey ES, Stratford KJ, Betts PR & Voss LD 1996 Psychological response to growth hormone treatment in short normal children. Archives of Diseases of Childhood 75 32-35.
67. Downie AB, Mulligan J, Stratford RJ, Betts PR & Voss LD 1997 Are short normal children at a disadvantage? The Wessex growth study. British Medical Journal 314 97-100.
68. Drake WM, Coyte D, Camacho-Hubner C, Jivanji NM, Kaltsas G, Wood DF, Trainer PJ, Grossman AB, Besser GM & Monson JP 1998 Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. Journal of Clinical Endocrinology and Metabolism 83 3913-3919.
69. Drake WM, Howell SJ, Monson JP & Shalet SM 2001a Optimizing GH therapy in adults and children. Endocrine Reviews 22 425-450.
70. Drake WM, Rodriguez-Arnao J, Weaver JU, James IT, Coyte D, Spector TD, Besser GM & Monson JP 2001b The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study. Clinical Endocrinology 54 525-532.
71. Eiser C & Morse R 2001 The measurement of quality of life in children: past and future perspectives. Journal of Developmental and Behavioural Pediatrics 22 248-256.
72. Ekman B, Ohman PK, Arnqvist HJ, Lindstrom T & Nystrom FH 2002 Individualized growth hormone substitution with normalized IGF-I levels does not stimulate the renin-angiotensin-aldosterone system. Clinical Endocrinology 57 473-479.
73. Erling A, Wiklund I & Albertsson-Wikland K 1995 The well-being of short-statured children. Quality of Life Research 4 422-423.
74. Feinberg I 2000 Slow wave sleep and release of growth hormone. Journal of the American Medical Association 284 2717-2718.
75. Ferrans CE 1996 Development of a conceptual model of quality of life. Scholarly Inquiry for Nursing Practice 10 293-304.
76. Florkowski CM, Stevens I, Joyce P, Espiner EA & Donald RA 1998 Growth hormone replacement does not improve psychological well-being in adult hypopituitarism: a randomized crossover trial. Psychoneuroendocrinology 23 57-63.
77. Frago LM, Paneda C, Dickson SL, Hewson AK, Argente J & Chowen JA 2002 Growth hormone (GH) and GH-releasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in neuroprotection. Endocrinology 143 4113-4122.
78. Galatzer A, Aran O, Nagelberg N, Ributzik N & Laron Z 1993 Cognitive and psychosocial functioning of young adults with Laron Syndrome. In Lessons from Laron Syndrome, pp 53-60. Eds Z Laron & JS Parks. Basel: Karger.
79. Gibney J, Wallace JD, Spinks T, Schnorr L, Ranicar A, Cuneo RC, Lockhart S, Burnand KG, Salomon F, Sonksen PH & Russell-Jones D 1999 The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients. Journal of Clinical Endocrinology and Metabolism 84 2596-2602.
80. Gilchrist FJ, Murray RD & Shalet SM 2002 The effect of long-term untreated growth hormone deficiency (GHD) and 9 years of GH replacement on the quality of life (QoL) of GH-deficient adults. Clinical Endocrinology 57 363-370.
81. Gill TM & Feinstein AR 1994 A critical appraisal of the quality of quality-of-life measurements. Journal of the American Medical Association 272 619-626.
82. Gilmour J & Skuse D 1996 Short stature - the role of intelligence in psychosocial adjustment. Archives of Diseases of Childhood 75 25-31.
83. Giusti M, Meineri I, Malagamba D, Cuttica CM, Fattacciu G, Menichini U, Rasore E & Giordano G 1998 Impact of recombinant human growth hormone treatment on psychological profiles in hypopituitary patients with adul-onset growth hormone deficiency. European Journal of Clinical Investigation 28 13-19.
84. Goldfarb AH & Jamurtas AZ 1997 Beta-endorphin response to exercise. Air update. Sports Medicine 24 8-16.
85. Hanukoglu A, Belutserkovsky O & Phillip M 2001 Growth hormone activates renin-aldosterone system in children with idiopathic short stature and in a pseudohypoaldosteronism patient with a mutation in epithelial sodium channel alpha subunit. Journal of Steroid Biochemistry and Molecular Biology 77 49-57.
86. Harvey S & Hull KL 2003 Neural growth hormone: an update. Journal of Neurobiology 20 1-14.
87. Haverkamp F & Necker M 1998 'Short stature in children - a questionnaire for parents': a new instrument for growth disorder-specific psychosocial adaptation in children. Quality of life Research 7 447-455.
88. Hayashi M, Shimohira M, Saisho S, Shimozawa K & Iwakawa Y 1992 Sleep disturbance in children with growth hormone deficiency. Brain Development 14 170-174.
89. Herlitz H, Jonsson O & Bengtsson BA 1994 Effect of recombinant human growth hormone on Cellular sodium metabolism. Clinical Science 86 233-237.
90. Hernberg-Stahl F, Luger A, Abs R, Bengtsson BA, Feldt-Rasmussen U, Wilton P, Westberg B & Monson JP 2001 Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency. Journal of Clinical Endocrinology and Metabolism 86 5277-5281.
91. Herschbach P, Henrich G, Strasburger CJ, Feldmeier H, Marin F, Attanasio AM & Blum WE 2001 Development and psychometric properties of a disease-specific quality of life questionnaire for adult patients with growth hormone deficiency. European Journal of Endocrinology 145 255-265.
92. Hill DJ, Riley SC, Bassett NS & Waters MJ 1992 Localization of the growth hormone receptor, identified by immunocytochemistry, in second trimester human fetal tissues and in placenta throughout gestation. Journal of Clinical Endocrinology and Metabolism 75 646-650.
93. Hokken-Koelega AC 1999 What is the role of GH therapy in children born small for gestational age? In Growth Hormone Therapy, pp 78-89. Ed JP Monson. Oxford: Blackwell Science.
94. Holmes SJ & Shalet SM 1995a Characteristics of adults who wish to enter a trial of growth hormone replacement. Clinical Endocrinology 42 613-618.
95. Holmes SJ & Shalet SM 1995b Factors influencing the desire for long-term growth hormone replacement in adults. Clinical Endocrinology 43 151-157.
96. Holmes SJ & Shalet SM 1995c Which adults develop side-effects of growth hormone replacement? Clinical Endocrinology 43 143-149.
97. Hull KL & Harvey S 2000 Growth hormone: a reproductive endocrine-paracrine regulator? Reviews of Reproduction 5 175-182.
98. Hull KL & Harvey S 2000 Growth hormone: roles in male reproduction. Endocrine 13 243-250.
99. Hull KL & Harvey S 2001 Growth hormone: roles in female reproduction. Journal of Endocrinology 168 1-23.
100. Janssen YJ, Doornbos J & Roelfsema F 1999 Changes in muscle volume, strength, and bioenergetics during recombinant human growth hormone (GH) therapy in adults with GH deficiency. Journal of Clinical Endocrinology and Metabolism 84 279-284.
101. Janssens H & Vauderschueren DM 2000 Endocrinological aspects of aging in men: is hormone replacement of benefit? European Journal of Obstetrics, Gynecology and Reproductive Biology 92 7-12.
102. Jenkins PJ, Fairclough PD, Richards T, Lowe DG, Monson J, Grossman A, Wass JA & Besser M 1997 Aeromegaly, colonic polyps and carcinoma. Clinical Endocrinology 47 17-22.
103. Johansson JO, Landin K, Tengborn L, Rosen T & Bengtsson BA 1994 High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults. Arterioslerosis and Thrombosis 14 434-437.
104. Johansson JO, Larson G, Andersson M, Elmgren A, Hynsjo L, Lindahl A, Lundberg PA, Isaksson OG, Lindstedt S & Bengtsson BA 1995 Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the ceresbrospinal fluid and affects neurotransmitters. Neuroendocrinology 61 57-66.
105. Johansson G, Rosen T, Bosaeus I, Sjostrom L & Bengtsson BA 1996 Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. Journal of Clinical Endocrinology and Metabolism 81 2865-2873.
106. Johansson AG, Engstrom BE, Ljunghall S, Karlsson FA & Burman P 1999 Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency. Journal of Clinical Endocrinology and Metabolism 84 2002-2007.
107. Johnston DG 1997 Growth hormone deficiency and quality of life in hypopituitary adults. Clinical Endocrinology 46 407-408.
108. Jonsson B & Nilsson B 2000 The impact of pituitary adenoma on morbidity. Increased sick leave and disability retirement in a cross-sectional analysis of Swedish national data. Pharmacoeconomics 18 73-81.
109. Jorgensen JO 1999 Two hot topics in the field of GH therapy: quality of life in hypopituitary adults, and clinical implications of the somatopause. Report from an interactive discussion. Journal of Endocrinological Investigation 22 150-156.
110. Juul A, Behrenscheer A, Tims T, Nielsen B, Halkjaer-Kristensen J & Skakkebaek NE 1993 Impaired thermoregulation in adults with growth hormone deficiency during heat exposure and exercise. Clinical Endocrinology 38 237-244.
111. Kern W, Halder R, al Reda S, Spath-Schwalbe E, Fehm HL & Born J 1993 Systemic growth hormone does not affect human sleep. Journal of Clinical Endocrinology and Metabolism 76 1428-1432.
112. Kinney BA, Coschigano KT, Kopchick JJ, Steger RW & Bartke A 2001 Evidence that age-induced decline in memory retention is delayed in growth hormone resistant GH-R-KO (Laron) mice. Physiology and Behaviour 72 653-660.
113. Kornreich L, Horev G, Schwarz M, Karmazyn B & Laron Z 2002 Craniofacial and brain abnormalities in Laton syndrome (primary growth hormone insensitivity). European Journal of Endocrinology 146 499-503.
114. Kranzler JH, Rosenbloom AL, Martinez V & Guevara-Aguirre J 1998 Normal intelligence with severe insulin-like growth factor I deficiency due to growth hormone receptor deficiency: a controlled study in a genetically homogeneous population. Journal of Clinical Endocrinology and Metabolism 83 1953-1958.
115. Lai ZN, Emtner M, Roos D & Nyberg F 1991 Characterization of putative growth hormone receptors in human choroid plexus. Brain Research 546 222-226.
116. Lai Z, Roos P, Zhai O, Olsson Y, Fholenhag K, Larsson C & Nyberg F 1993 Age-related reduction of human growth hormone-binding sites in the human brain. Brain Research 621 260-266.
117. Laron Z 2001 Consequences of not treating children with Laron syndrome (primary growth hormone insensitivity). Journal of Pediatric Endocrinology and Metabolism 14 (Suppl 5) 1243-1248.
118. Laron Z & Klinger B 2000 Comparison of the growth-promoting effects of insulin-like growth factor I and growth hormone in the early years of life. Acta Paediatrica 89 38-41.
119. Le Greves M, Steesland P, Le Greves P & Nyberg F 2002 Growth hormone induces age-dependent alteration in the expression of hippocampal growth hormone receptor and N-methyl-D-aspartate receptor subunits gene transcripts in male rats. PNAS 99 7119-7123.
120. Lehmann ED, Hopkins KD, Weissberger AJ, Gosling RG & Sonksen PH 1993 Aortic distensibility in growth hormone deficient adults. Lancet 341 309.
121. Leidl R & Stratmann D 1998 Economic evaluation is essential in healthcare for the elderly. A viewpoint. Drugs and Aging 13 255-262.
122. Leplege A & Hunt S 1997 The problem of quality of life in medicine. Journal of the American Medical Association 278 47-50.
123. Li Voon Chong JS, Groves T, Foy P, Wallymahmed ME & MacFarlane IA 2002 Elderly people with hypothalamic-pituitary disease and untreated GH deficiency: clinical outcome, body composition, lipid profiles and quality of life after 2 years compared to controls. Clinical Endocrinology 56 175-181.
124. Lobie PE, Breipohl W, Lincoln DT, Garcia-Aragon J & Waters MJ 1990 Localization of the growth hormone receptor/binding protein in skin Journal of Endocrinology 126 467-471.
125. Longobardi S, Cuocolo A, Merola B, Di Rella F, Colao A, Nicolai E, Cardei S, Salvatore M & Lombardi G 1998 Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency. Clinical Endocrinology 48 137-143.
126. Lynch S, Merson S, Beshyah SA, Skinner E, Sharp P, Priest RG & Johnston DG 1994 Psychiatric morbidity in adults with hypopituitarism. Journal of the Royal Society of Medicine 87 445-447.
127. Lynch CD, Cooney PT, Bennett SA, Thornton PL, Khan AS, Ingram RL & Sonntag WE 1999 Effects of moderate caloric restriction on cortical microvascular density and local cerebral blood flow in aged rats. Neurobiology of Aging 20 191-200.
128. McGauley GA 1989 Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency. Acta Pediatrica Scandinavia Supplement 356 70-72.
129. McKenna SP & Doward LC 1999 What is the impact of GH deficiency and GH replacement on quality of life in childhood-onset and adult-onset GH deficiency? In Growth Hormone Therapy, pp 160-176. Ed JP Monson. London: Blackwell Science.
130. McKenna SP, Doward LC, Alonso J, Kohlmann T, Niero M, Prieto L & Wiren L 1999 The QoL-AGHDA: an instrument for the assessment of quality of life in adult with growth hormone deficiency. Quality of Life Research 8 373-383.
131. Mardh G, Lundin K, Borg G, Jonsson B & Lindeberg A 1994 Growth hormone replacement therapy in adult hypopituitary patients with growth hormone deficiency: combined data from 12 European placebo-controlled trials. Endocrinology and Metabolism 1 (Suppl) 43-49.
132. Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides N & Johnston DG, 1992 Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet 340 1188-1192.
133. Mehta A & Hindmarsh PC 2002 The use of somatropin (recombinant growth hormone) in children of short stature. Paediatric Drugs 4 37-47.
134. Merola B, Longobardi S, Sofia M, Pivonello R, Micco A, Di Rella F, Esposito V, Colao A & Lombardi G 1996 Lung volumes and respiratory muscle strength in adult patients with childhood- or adult-onset growth hormone deficiency: effect of 12 months' growth hormone replacement therapy. European Journal of Endocrinology 135 553-558.
135. Moller J, Frandsen E, Fisker S, Jorgensen JO & Christiansen JS 1996 Decreased plasma and extracellular volume in growth hormone deficient adults and the acute and prolonged effects of GH administration: a controlled experimental study. Clinical Endocrinology 44 533-539.
136. Monson JP 1999 Growth Hormone Therapy. Oxford: Blackwell Science.
137. Monson JP, Abs R, Bengtsson BA, Bennmarker H, Feldt R, Hernberg S, Thoren M, Westberg B, Wilton P & Wuster C 2000 Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database. Clinical Endocrinology 53 281-289.
138. Monson JP, Drake WM, Carroll PV, Weaver JU, Rodriguez-Arnao J & Savage MO 2002 Influence of growth hormone on accretion of bone mass. Hormone Research 58 (Suppl 1) 52-56.
139. Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A & Shalet SM 1999a Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults. Clinical Endocrinology 50 749-757.
140. Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A, Smethurst LE & Shalet SM 1999b Influences on quality of life in GH deficient adults and their effect on response to treatment. Clinical Endocrinology 51 565-573.
141. Murray RD, Darzy KH, Gleeson HK & Shalet SM 2002 GH-deficient survivors of childhood cancer: GH replacement during adult life. Journal of Clinical Endocrinology and Metabolism 87 129-135.
142. Nass R, Huber KM, Klauss V, Muller OA, Schopohl J & Strasburger CJ 1995 Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood. Journal of Clinical Endocrinology and Metabolism 80 552-557.
143. Nicholas LM, Tancer ME, Silva SG, Underwood LE & Stabler B 1997 Short stature, growth hormone deficiency, and social anxiety. Psychosomatic Medicine 59 372-375.
144. Nyberg F 2000 Growth hormone in the brain: characteristics of specific brain targets for the hormone and their functional significance. Frontiers in Neuroendocrinology 21 330-348.
145. Nyberg F & Burman P 1996 Growth hormone and its receptors in the central nervous system - location and functional significance. Hormone Research 45 18-22.
146. Orme SM, McNally RJ, Cartwright PA & Belchetz PE 1998 Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. Journal of Clinical Endocrinology and Metabolism 83 2730-2734.
147. Page RC, Hammersley MS, Burke CW & Wass JA 1997 An account of the quality of life of patients after treatment for non-functioning pituitary tumours. Clinical Endocrinology 46 401-406.
148. Papadakis MA, Grady D, Black D, Tierney MJ, Gooding GA, Schambelan M & Grunfeld C 1996 Growth hormone replacement in healthy older men improves body composition but not functional ability. Annals of Internal Medicine 124 708-716.
149. Pedersen SA, Welling K, Michaelsen KF, Jorgensen JO, Christiansen JS & Skakkebaek NE 1989 Reduced sweating in adults with growth hormone deficiency. Lancet 2 681-682.
150. Pilpel D, Leiberman E, Zadik Z & Carel CA 1995 Effect of growth hormone treatment on quality of life of short-stature children. Hormone Research 44 1-5.
151. Rekers-Mombarg LT, Busschbach JJ, Massa GG, Dicke J & Wit JM 1998 Quality of life of young adults with idiopathic short stature: effect of growth hormone treatment. Dutch Growth Hormone Working Group. Acta Paediatrica 87 865-870.
152. Reutens AT, Hoffman DM, Leung K-C & Ho KKY 1995 Evaluation and application of a highly sensitive assay for serum growth hormone in the study of adult GH deficiency. Journal of Clinical Endocrinology and Metabolism 80 480-485.
153. Rikken B, van Busschbach J, le Cessie S, Manten W, Spermon T, Grobbee R & Wit JM 1995 Impaired social status of growth hormone deficient adults as compared to controls with short or normal stature. Dutch Growth Hormone Working Group. Clinical Endocrinology 43 205-211.
154. Risby ED, Hsiao JK, Sunderland T, Agren H, Rudorfer MV & Potter WZ 1987 The effects of antidepressants on the cerebrospinal fluid homovanillic acid/5-hydroxyindoleacetic acid ratio. Clinical Pharmacology and Therapeutics 42 547-554.
155. Rosen CJ 2000 Growth hormone and aging. Endocrine 12 197-201.
156. Rosen T, Wiren L, Wilhelmsen L, Wiklund I & Bengtsson BA 1994 Decreased psychological well-being in adult patients with growth hormone deficiency. Clinical Endocrinology 40 111-116.
157. Rosen T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G & Bengtsson BA 1997 Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. European Journal of Endocrinology 137 240-245.
158. Rosenfeld RG, Frane J, Attie KM, Brasel JA, Burstein S, Cara JF, Chernausek S, Gotlin RW, Kuntze J & Lippe BM 1992 Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome. Journal of Pediatrics 121 49-55.
159. Ross JL, Feuillan P, Kushner H, Roeltgen D & Cutler GB Jr 1997 Absence of growth hormone effects on cognitive function in girls with Turner syndrome. Journal of Clinical Endocrinology and Metabolism 82 1814-1817.
160. Rudman D 1985 Growth hormone, body composition, and aging. Journal of the American Geriatrics Society 33 800-807.
161. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW & Mattson DE 1990 Effects of human growth hormone in men over 60 years old. New England Journal of Medicine 323 1-6.
162. Salomon F, Cuneo RC, Hesp R & Sonksen PH 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine 321 1797-1803.
163. Sandberg DE, MacGillivray MH, Clopper RR, Fung C, LeRoux L & Alliger DE 1998 Quality of life among formerly treated childhood-onset growth hormone-deficient adults: a comparison with unaffected siblings. Journal of Clinical Endocrinology and Metabolism 83 1134-1142.
164. Sartorio A & Narici MV 1994 Growth hormone (GH) treatment in GH-deficient adults: effects on muscle size, strength and neural activation. Clinical Physiology 14 527-537.
165. Sartorio A, Molinari E, Riva G, Conti A, Morabito F & Faglia G 1995 Growth hormone treatment in adults with childhood onset growth hormone deficiency: effects on psychological capabilities. Hormone Research 44 6-11.
166. Sartorio A, Conti A, Molinari E, Riva G, Morabito F & Faglia G 1996 Growth, growth hormone and cognitive functions. Hormone Research 45 23-29.
167. Sartorio A, Ferrero S, Court A, Bragato R, Malfatto G, Leonetti G & Faglia G 1997 Adults with childhood-onset growth hormone deficiency: effects of growth hormone treatment on cardiac structure. Journal of Internal Medicine 241 515-520.
168. Savine R & Sonksen P 2000 Growth hormone - hormone replacement for the somatopause? Hormone Research 53 (Suppl 3) 37-41.
169. Scheepens A, Sirimanne E, Beilharz E, Breier BH, Waters MJ, Gluckman PD & Williams CE 1999 Alterations in the neural growth hormone axis following hypoxic-ischemic brain injury. Brain Research Molecular Brain Research 68 88-100
170. Scheepens A, Williams CE, Breier BH, Guan J & Gluckman PD 2000 A role for the somatotropic axis in neural development, injury and disease. Journal of Pediatric Endocrinology and Metabolism 13 (Suppl 6) 1483-1491.
171. Scheepens A, Sirimanne ES, Breier BH, Clark RG, Gluckman PD & Williams CE 2001 Growth hormone as a neuronal rescue factor during recovery from CNS injury. Neuroscience 104 677-687.
172. Schneider-Rivas S, Rivas-Arancibia S, Vazquez-Pereyra F, Vazquez-Sandoval R & Borgonio-Perez G 1995 Modulation of long-term memory and extinction responses induced by growth hormone (GH) and growth hormone releasing hormone (GHRH) in rats. Life Sciences 56 L433-L441.
173. Sesmilo G, Biller BM, Llevadot J, Hayden D, Hanson G, Rifai N & Klibanski A 2000 Effects of growth hormone administration on inflammatory and other cardiovascular risk markets in men with growth hormone deficiency. A randomized, controlled clinical trial. Annals of Internal Medicine 133 111-122.
174. Shahi M, Beshyah SA, Hackett D, Sharp PS, Johnston DG & Foale RA 1992 Myocardial dysfunction in treated adult hypopituitarism: a possible explanation for increased cardiovascular mortality. British Heart Journal 67 92-96.
175. Shalet SM 1998 Growth hormone therapy for adult growth hormone deficiency. International Journal of Clinical Practice 52 108-111.
176. Simpson H, Savine R, Sonksen P, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, Raymond Hintz PC, Ho K, Mullis P et al. 2002 Growth hormone replacement therapy for adults: into the new millennium. Growth Hormone and IGF Research 12 1-33.
177. Skuse D, Gilmour J, Tian CS & Hindmarsh P 1994 Psychosocial assessment of children with short stature: a preliminary report. Acta Pediatrica Scandinavia Supplement 406 11-16.
178. Soares CN, Musolino NR, Cunha NM, Caires MA, Rosenthal MC, Camargo CP & Bronstein MD 1999 Impact of recombinant human growth hormone (RH-GH) treatment on psychiatric, neuropsychological and clinical profiles of GH deficient adults. A placebo-controlled trial. Arquivos de Neuropsiquiatria 57 182-189.
179. Sonntag WE, Lynch CD, Cefalu WT, Ingram RL, Bennett SA, Thornton PL & Khan AS 1999 Pleiotropic effects of growth hormone and insulin-like growth factor (IGF)-I on biological aging: inferences from moderate caloric-restricted animals. Journal of Gerentology A: Biological Sciences and Medical Sciences 54 B521-B538.
180. Sonntag WE, Lynch C, Thornton P, Khan A, Bennett S & Ingram R 2000 The effects of growth hormone and IGF-I deficiency on cerebrovascular and brain ageing. Journal of Anatomy 197 575-585.
181. Stabler B 2001 Impact of growth hormone (GH) therapy on quality of life along the lifespan of GH-treated patients. Hormone Research 56 (Suppl 1) 55-58.
182. Stabler B, Turner JR, Girdler SS, Light KC & Underwood LE 1992 Reactivity to stress and psychological adjustment in adults with pituitary insufficieny. Clinical Endocrinology 36 467-473.
183. Stabler B, Clopper RR, Siegel PT, Stoppani C, Compton PG & Underwood LE 1994 Academic achievement and psychological adjustment in short children. The National Cooperative Growth Study. Journal Developmental and Behavioural Pediatrics 15 1-6.
184. Stabler B, Clopper RR, Siegel PT, Nicholas LM, Silva SG, Tancer ME & Underwood LE 1996 Links between growth hormone deficiency, adaptation and social phobia. Hormone Research 45 30-33.
185. Stabler B, Siegel PT, Clopper RR, Stoppani CE, Compton PG & Underwood LE 1998 Behavior change after growth hormone treatment of children with short stature. Journal of Pediatrics 133 366-373.
186. Sverrisdottir YB, Elam M, Herlitz H, Bengtsson BA & Johannsson G 1998 Intense sympathetic nerve activity in adults with hypopituitarism and untreated growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 83 1881-1885.
187. Takano K, Tanaka T & Saito T 1994 Psychosocial adjustment in a large cohort of adults with growth hormone deficiency treated with growth hormone in childhood: summary of a questionnaire survey. Committee for the Study Group of Adult GH Deficiency. Acta Pediatrica Scandinavia Supplement 399 16-19.
188. Tan U 1995 Growth hormone limits the brain/body development before birth in relation to sex, grasp-reflex asymmetry and familial sinistrality of human neonates. International Journal of Neuroscience 82 105-111.
189. Tauber M, Moulin P, Pienkowski C, Jouret B & Rochiccioli P 1997 Growth hormone (GH) retesting and auxological data in 131 GH-deficient patients after completion of treatment. Journal of Clinical Endocrinology and Metabolism 82 352-356.
190. Ter Maaten JC, de Boer H, Kamp O, Stuurman L & van der Veen EA 1999 Long-term effects of growth hormone (GH) replacement in men with childhood-onset GH deficiency. Journal of Clinical Endocrinology and Metabolism 84 2373-2380.
191. Theunissen NC, Kamp GA, Koopman HM, Zwinderman KA, Vogels T & Wit JM 2002 Quality of life and self-esteem in children treated for idiopathic short stature. Journal Pediatrics 140 507-515.
192. Thornton PL, Ingram RL & Sonntag WE 2000 Chronic [D-Ala2]-growth hormone-releasing hormone administration attenuates age-related deficits in spatial memory. Journal of Gerontology A: Biological Sciences and Medical Sciences 55 B106-B112.
193. Tinklin TS & Betts PR 1999 What is the Current status of GH therapy in children with Turner syndrome? In Growth Hormone Therapy, pp 19-35. Ed JP Monson. Oxford: Blackwell Science.
194. Toogood AA & Shalet SM 1999 Growth hormone replacement therapy in the elderly with hypothalamic-pituitary disease: a dose-finding study. Journal of Clinical Endocrinology and Metabolism 84 131-136.
195. Toogood AA, O'Neill PA & Shalet SM 1996 Beyond the somatopause: growth hormone deficiency in adults over the age of 60 years. Journal of Clinical Endocrinology and Metabolism 81 460-465.
196. Toogood AA, Nass RM, Pezzoli SS, O'Neill PA, Thorner MO & Shalet SM 1997 Preservation of growth hormone pulsatility despite pituitary pathology, surgery, and irradiation. Journal of Clinical Endocrinology and Metabolism 82 2215-2221.
197. Vahl N, Moller N, Lauritzen T, Christiansen JS & Jorgensen JO 1997 Metabolic effects and pharmacokinetics of a growth hormone pulse in healthy adults: relation to age, sex, and body composition. Journal of Clinical Endocrinology and Metabolism 82 3612-3618.
198. Valcavi R, Gaddi O, Zini M, Iavicoli M, Mellino U & Portioli I 1995 Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment. Journal of Clinical Endocrinology and Metabolism 80 659-666.
199. Van Cauter E, Leproult R & Plat L 2000 Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. Journal of the American Medical Association 284 861-868.
200. Van der Reijden IE, Slijper FM, van Dongen JE, de Waal WJ & Verhulst FC 1996 Self-concept before and after two years of growth hormone treatment in intrauterine growth-retarded children. Hormone Research 46 88-94.
201. Van der Reijden IE, de Sonneville LM, Swaab HJ, Slijper FM & Verhulst FC 1997 Evaluation of attention before and after 2 years of growth hormone treatment in intrauterine growth retarded children. Journal of Clinical and Experimental Neuropsychology 19 101-118.
202. Vance ML & Mauras N 1999 Growth hormone therapy in adults and children. New England and Journal of Medicine 341 1206-1216.
203. Vandeweghe M, Taelman P & Kaufman JM 1993 Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clinical Endocrinology 39 409-415.
204. Varni JW, Seid M & Kurtin PS 2001 PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Medical Care 39 800-812.
205. Verhelst J & Abs R 2002 Long-term growth hormone replacement therapy in hypopituitary adults. Drugs 62 2399-2412.
206. Verhelst J, Abs R, Vandeweghe M, Mockel J, Legros JJ, Copinschi G, Mahler C, Velkeniers B, Vanhaelst L, Van Aelst A et al. 1997 Two years of replacement therapy in adults with growth hormone deficiency. Clinical Endocrinology 47 485-494.
207. Vihervuori E, Virtanen M, Koistinen H, Koistinen R, Seppala M & Siimes MA 1996 Hemoglobin level is linked to growth hormone-dependent proteins in short children. Blood 87 2075-2081.
208. Wallymahmed ME, Baker GA, Humphris G, Dewey M & MacFarlane IA 1996 The development, reliability and validity of a disease specific quality of life model for adults with growth hormone deficiency. Clinical Endocrinology 44 403-411.
209. Wallymahmed ME, Foy P, Shaw D, Hutcheon R, Edwards RH & MacFarlane IA 1997 Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years. Clinical Endocrinology 47 439-446.
210. Wallymahmed ME, Foy P & MacFarlane IA 1999 The quality of life of adults with growth hormone deficiency: comparison with diabetic patients and control subjects. Clinical Endocrinology 51 333-338.
211. Weissberger AJ, Anastasiadis AD, Sturgess I, Martin FC, Smith MA & Sonksen PH 2003 Recombinant human growth hormone treatment in elderly patients undergoing elective total hip replacement. Clinical Endocrinology 58 99-107.
212. Whitehead HM, Boreham C, McIlrath EM, Sheridan B, Kennedy L, Atkinson AB & Hadden DR 1992 Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clinical Endocrinology 36 45-52.
213. Wiklund I, Wiren L, Erling A, Karlberg J & Albertsson W 1994 A new self-assessment questionaire to measure well-being in children, particularly those of short stature. Quality of Life Research 3 449-455.
214. Wiren L, Bengtsson BA & Johannsson G 1998 Beneficial effects of long-term GH replacement therapy on quality of life in adults with GH deficiency. Clinical Endocrinology 48 613-620.
215. Wiren L, Whalley D, McKenna S & Wilhelmsen L 2000 Application of a disease-specific, quality-of-life measure (QoL-AGHDA) in growth hormone-deficient adults and a random population sample in Sweden: validation of the measure by Rasch analysis. Clinical Endocrinology 52 143-152.
216. Wiren L, Johannsson G & Bengtsson BA 2001 A prospective investigation of quality of life and psychological well-being after the discontinuation of GH treatment in adolescent patients who had GH deficiency during childhood. Journal of Clinical Endocrinology and Metabolism 86 3494-3498.
217. Woodhouse LJ, Asa SL, Thomas SG & Ezzat S 1999 Measures of submaximal aerobic performance evaluate and predict functional response to growth hormone (GH) treatment in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism 84 4570-4577.
218. World Health Organization 1947 World Health Organization Constitution. Switzerland: World Health Organization.
219. Zenker S, Haverkamp F & Klingmuller D 2002 Growth hormone deficiency in pituitary disease: relationship to depression, apathy and somatic complaints. European Journal of Endocrinology 147 165-171.
220. Zogopoulos G, Figuereido R, Jenab A, Ali Z, Lefebvre Y & Goodyer CG 1996 Expression of exon 3-retaining and -deleted human growth hormone receptor messenger ribonucleic acid isoforms during development. Journal of Clinical Endocrinology and Metabolism 81 775-782.